TrialGene therapy2013

Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial.

D Gaudet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.